Resolvin E3 attenuates allergic airway inflammation via the interleukin-23-interleukin-17A pathway.
Sato M, Aoki-Saito H, Fukuda H, Ikeda H, Koga Y, Yatomi M, Tsurumaki H, Maeno T, Saito T, Nakakura T, Mori T, Yanagawa M, Abe M, Sako Y, Dobashi K, Ishizuka T, Yamada M, Shuto S, Hisada T.
Sato M, et al. Among authors: saito t.
FASEB J. 2019 Nov;33(11):12750-12759. doi: 10.1096/fj.201900283R. Epub 2019 Aug 30.
FASEB J. 2019.
PMID: 31469599
Free PMC article.
Our results accordingly identify RvE3 as a potential therapeutic target for the management of asthma.-Sato, M., Aoki-Saito, H., Fukuda, H., Ikeda, H., Koga, Y., Yatomi, M., Tsurumaki, H., Maeno, T., Saito, T., Nakakura, T., Mori, T., Yana …
Our results accordingly identify RvE3 as a potential therapeutic target for the management of asthma.-Sato, M., Aoki-Saito, H., Fukud …